Diabetic ketoalkalosis: a rare potentially dangerous condition in emergency endocrinology practice
https://doi.org/10.52485/19986173_2025_2_84
Abstract
Diabetic ketoalkalosis (DK) is a rare but potentially severe complication of diabetes mellitus, requiring emergency medical intervention. The main triggering factors for DK include infectious diseases, surgical procedures and trauma. The pathogenesis of DK involves processes related to reduced circulating blood volume due to persistent vomiting, leading to hydrogen ion loss and elevated blood bicarbonate levels, ultimately resulting in alkalemia. The clinical manifestations of DK resemble those of diabetic ketoacidosis (DKA), except for the presence of intractable vomiting, a symptom specific to DK patients. The diagnosis of DK is primarily confirmed through laboratory findings, including metabolic alkalosis (pH > 7,3 or blood bicarbonate > 18,0 mmol/L) and a delta ratio exceeding 2,0. Differential diagnosis should exclude classic DKA, euglycemic DKA, and hyperglycemic hyperosmolar state. The principles of intensive care for DK are similar to those for DKA and include: fluid resuscitation with isotonic crystalloid solutions to correct dehydration, electrolyte imbalance correction (primarily hypokalemia), intravenous short-acting insulin therapy. Despite its potential severity, DK can be successfully managed without serious complications or fatal outcomes if diagnosed and treated promptly and correctly.
Keywords
About the Author
Yu. V. BykovRussian Federation
Candidate of Medical Sciences, Assistant
Department of Anesthesiology and Intensive Care with a course of Additional Professional Education
355017; 310 Mira St.; 355002; 3 Semashko St.; Stavropol
References
1. Jaramillo J., Joseph M., Aldubayan M. et al. New Test, Old Disease: A Case Series of Diabetic Ketoalkalosis. J Emerg Med. 2020. 58(1). 9-16. DOI: 10.1016/j.jemermed.2019.10.002.
2. Yigazu D.M., Lema M., Bekele F. et al. Diabetic ketoacidosis treatment outcomes and its associated factors among adult patients with diabetes mellitus admitted to public hospitals in Nekemte Town, Ethiopia: a cross-sectional study. Front Clin Diabetes Healthc. 2025. 5. 1446543. DOI: 10.3389/fcdhc.2024.1446543.
3. Hossain J., Al‐Mamun M., Islam R. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep. 2024. 7(3). 2004. DOI: 10.1002/hsr2.2004.
4. Yang L., Xie D., Liu F. et al. Global and Regional Burden of Type 2 Diabetes Mellitus Attributable to Low Physical Activity From 1990 to 2021. J Diabetes. 2025. 17(1). 70043. DOI: 10.1111/1753-0407.70043.
5. Tomic D., Shaw J.E., Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022. 18(9). 525-539. DOI: 10.1038/s41574-022-00690-7.
6. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077-2093. DOI: 10.1016/S0140-6736(24)02317-1.
7. Cao S., Cao S. Diabetic Ketoalkalosis: A Common Yet Easily Overlooked Alkalemic Variant of Diabetic Ketoacidosis Associated with Mixed Acid-Base Disorders. J Emerg Med. 2023. 64. 282–288. DOI: 10.1016/j.jemermed.2022.12.023
8. Randazzese S.F., La Rocca M., Bombaci B. et al. Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes: Ongoing Challenges in Care. Children (Basel). 2025. 12(1). 110. DOI: 10.3390/children12010110.
9. Nanavati S., Kumar V., Melki G. et al. Diabetic ketoalkalosis: misnomer or undiagnosed variant of diabetic ketoacidosis. BMJ Case Rep. 2018. 2018. bcr2018226092. DOI: 10.1136/bcr-2018-226092
10. Bykov Yu.V. Diabetic ketoacidosis in children and adolescents: from pathophysiology to prevention. Zabaikalsky Medical Bulletin. 2021. (2). 85-95.
11. Bykov Yu.V., Obidin A.N., Zinchenko O.V. et al. Diabetic ketoacidosis in pediatric practice: studies. stipend. Stavropol: Publishing house of SGMU. 2023. 60.
12. Dashora U., Patel D.C., Gregory R. et al. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium–glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020). Diabet Med. 2021. 38. 14458.
13. Mehta A.E., Zimmerman R. Classic diabetic ketoacidosis and the euglycemic variant: Something old, something new. Cleve Clin J Med. 2025. 92(1). 33-39. DOI: 10.3949/ccjm.92a.24075.
14. Mookpaksacharoen O., Choksakunwong S., Lertwattanarak R. Comparison of clinical characteristics and treatment outcomes between initially diagnosed type 1 and type 2 diabetes mellitus patients presenting with diabetic ketoacidosis. BMC Endocr Disord. 2024. 24(1). 114. DOI: 10.1186/s12902-024-01649-7.
15. Bykov Yu.V., Obidin A.N., Fischer V.V. et al. Cerebral edema in diabetic ketoacidosis in children and adolescents: pathophysiological mechanisms and clinical manifestations. The science of youth. 2024. 12(4). 664-672.
16. Pandey D.G., Sharma S. Biochemistry, Anion Gap. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2025. Bookshelf ID: NBK539757
17. Gosmanov A.R., Gosmanova E.O., Kitabch A.E. et al. Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2021. Bookshelf ID: NBK279052
18. Yıldırımçakar D., Öcal M., Altıncık S.A. et al. Hyperchloremia and Prolonged Acidosis During Treatment for Pediatric Diabetic Ketoacidosis. Pediatr Emerg Care. 2024. 40(12). 856-860. DOI: 10.1097/PEC.0000000000003280.
19. Morikawa M.J., Ganesh P.R. Acid-Base Interpretation: A Practical Approach. Am Fam Physician. 2025. 111(2). 148-155.
20. Jung S.W., Park E.J., Kim J.S. et al. Renal tubular acidosis in patients with primary Sjögren’s syndrome. Electrolyte Blood Press. 2017. 15. 17-22. DOI: 10.5049/EBP.2017.15.1.17
21. Ashinze P., Mafua N., Banerjee S. et al. Diabetic ketoalkalosis: the dark, torrid horse of diabetic emergencies. Explor Med. 2024. 5. 544–552 DOI: 10.37349/emed.2024.00238
22. Brill A., Chheda N., Strama D. et al. Diabetic Ketoalkalosis: A Case Report. Clin Pract Cases Emerg Med. 2024. 8(2). 111-114. DOI: 10.5811/cpcem.1389.
23. Hirooka N., Koga A., Fujii H. et al. Developing diabetic ketoalkalosis in a patient with Cushing disease. Diabetes Manag. 2017. 7(4). 322–326.
24. Wuttiputhanun T., Townamchai N., Eiam-Ong S. et al. Metabolic alkalosis masked presentation of diabetic ketoacidosis: A case report. Clin Case Rep. 2023. 11(12). 8250. DOI: 10.1002/ccr3.8250.
25. Messersmith A.L., Bayrakdar K., Killeen D. Case Of Diabetic Ketoacidosis Obscured By Metabolic Alkalosis In An Individual With End-stage Renal Disease. Journal of the Endocrine Society. 2024. 8(1). 163.637. DOI: 1210/jendso/bvae163.637
26. Novotny W.E., Fiordalisi I., Keel C.P. et al. The potential effect of metabolic alkalosis on insulin sensitivity in an adolescent with new‐onset type 1 diabetes. Clin Case Rep. 2021. 9(5). 03915. DOI: 10.1002/ccr3.3915
27. Kumar V., Nanavati S.M., Komal F. et al. Ketoalkalosis: Masked presentation of diabetic ketoacidosis with literature review. J Endocrinol Metab. 2018. 7. 194–196.
28. Hillock M.F., Jarmon C., Metropulos A.E. et al. Diabetic ketoacidosis masked by both Euglycemia and a primary metabolic alkalosis. Oxf Med Case Reports. 2024. 2024(7). 071. DOI: 10.1093/omcr/omae071.
29. Pasquel F.J., Tsegka K., Wang H. et al. Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study. Diabetes Care. 2020. 43. 349–357. DOI: 10.2337/dc19-1168
30. Do C, Vasquez PC, Soleimani M. Metabolic Alkalosis Pathogenesis, Diagnosis, and Treatment: Core Curriculum 2022. Am J Kidney Dis. 2022. 80(4). 536–551. DOI: 10.1053/j.ajkd.2021.12.016.
31. Lu D, Song H, Liu IL et al. The Δ Anion Gap/Δ Bicarbonate Ratio in Lactic Acidosis: Time for a New Baseline? Kidney360. 2024. 5(9). 1251–1261. DOI: 10.34067/KID.0000000000000513
32. Rewers A., Kuppermann N., Stoner M.J. et al. Effects of Fluid Rehydration Strategy on Correction of Acidosis and Electrolyte Abnormalities in Children With Diabetic Ketoacidosis. Diabetes Care. 2021. 44(9). 2061–2068. DOI: 10.2337/dc20-3113
33. Umpierrez G.E., Davis G.M., ElSayed N.A. et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024. 67(8). 1455-1479. DOI: 10.1007/s00125-024-06183-8.
34. Eledrisi M.S., Elzouki A.N. Management of Diabetic Ketoacidosis in Adults : A Narrative Review. Saudi J Med Med Sci. 2020. 8(3). 165–173. DOI: 10.4103/sjmms.sjmms_478_19
35. Wolfsdorf J.I., Glaser N., Agus M. et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018. 19(27). 155–77. DOI: 10.1111/pedi.12701
36. Lizzo J.M., Goyal A., Gupta V. Adult Diabetic Ketoacidosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2025. Bookshelf ID: NBK560723
37. Goguen J., Gilbert J. Diabetes Canada Clinical Practice Guidelines Expert Committee. Hyperglycemic Emergencies in Adults. Can J Diabetes. 2018. 42 (1). 109–114. DOI: 10.1016/j.jcjd.2017.10.013
38. Elendu C., David J.A., Udoyen A.O. et al. Comprehensive review of diabetic ketoacidosis: an update. Ann Med Surg (Lond). 2023. 85(6). 2802–2807. DOI: 10.1097/MS9.0000000000000894
39. Messina N., Anderson Z., Saravis L. et al. Revisiting Diabetic Ketoacidosis (DKA) Fluid Management: Should Normal Saline Be Used? Cureus. 2025. 17(1). 77739. DOI: 10.7759/cureus.77739.
Supplementary files
Review
For citations:
Bykov Yu.V. Diabetic ketoalkalosis: a rare potentially dangerous condition in emergency endocrinology practice. Transbaikalian Medical Bulletin. 2025;(2):84-94. (In Russ.) https://doi.org/10.52485/19986173_2025_2_84